Similar articles

• The polycystic ovary syndrome. 1. Pathogenesis.

  White MC, Turner EI. White MC, et al. Br J Hosp Med. 1994 Feb 16-Mar 1;51(4):167-74. Br J Hosp Med. 1994. PMID: 8012678 Review.
• [Endocrine effects of laser vaporization of the ovaries in women with polycystic ovary syndrome].

  Rossmanith WG, Keckstein J, Spatzier K, Lauritzen C. Rossmanith WG, et al. Gynakol Rundsch. 1991;31 Suppl 2:333-5. Gynakol Rundsch. 1991. PMID: 1790971 German. No abstract available.
• Clinical manifestations of polycystic ovarian disease.

  Young RL, Goldzieher JW. Young RL, et al. Endocrinol Metab Clin North Am. 1988 Dec;17(4):621-35. Endocrinol Metab Clin North Am. 1988. PMID: 2973981 Review.
• Luteinizing hormone, adrenal androgenesis, and polycystic ovarian disease.

  Polansky S. Polansky S. Obstet Gynecol. 1975 Apr;45(4):451-4. Obstet Gynecol. 1975. PMID: 1121374
• [Current patholophysiologic and morphologic concepts of polycystic disease of the ovary].

  Vulkov I, Georgiev Ch. Vulkov I, et al. Akush Ginekol (Sofiia). 1982;21(3):238-43. Akush Ginekol (Sofiia). 1982. PMID: 6289691 Review. Bulgarian. No abstract available.